Medtronic Information Center: __________________ Problems with Medtronic Infuse Bone Growth Product Medtronic Infuse and Serious Issues Medtronic Infuse - Bone Graft Lawsuit Infuse Bone Graft Medtronic Bone Graft Lawsuit Medtronic Bone Graft Death Lawsuit FDA Warning on Medtronic Off-Label Use Cancer Concerns Raised by New Study on Medtronic Infuse Bone Graft

The Medtronic Corporation faces claims and lawsuits by thousands that had their medical product installed into their body at the time of or after neck surgery and then these individuals who have suffered injury or death as a result of its Infuse Bone Graft product.  

If you or a loved one has suffered serious complications as the result of a Medtronic Infuse Bone Graft, please contact us for a free case evaluation.

The Medtronic Infuse Lawsuit or Litigation is based upon evidence that Medtronic sales personnel allegedly encouraged doctors to use the Infuse Bone Graft for neck surgery, even though the FDA had not approved the product for use in neck surgery.  Off label use is against the law.  According to a Wall Street Journal Report, Medtronic also paid a surgeon $800,000 who allegedly fabricated a study reporting positive results for the Infuse Bone Graft.  The off label use of Infuse Bone Graft for neck surgeries and the attempt to mislead doctors and the public about the use of the product can form the basis of a lawsuit for failure to adequately warn of the dangerous side effects associated with the Infuse Bone Graft.  Reported dangerous side effects include unwanted bone growth, pain, male sterility, swelling of the airways, difficulty breathing, speaking and swallowing, and potentially paralysis and death.  Medtronic has paid $40,000,000 to settle whistleblower lawsuits over the company’s illegal activity relating to the Infuse Bone Graft.  The US Senate has launched an investigation into Medtronic’s conduct.

The Medtronic Infuse Bone Graft contains recombinant human Bone Morphogenetic Protein (rhBMP) which is a genetically engineered protein that initiates bone growth.  The Infuse Bone Graft was approved by the FDA for use in some back surgeries but not neck surgery.

Generally speaking if any of the following apply to you, you may qualify and should contact us for a free case evaluation.  We will investigate your case at no charge:

•     Difficulties swallowing, speaking, or breathing
•     Compression of airway
•     Impingement of nerves and nerve damage
•     Unwanted bone growth
•     Retrograde ejaculation
•     Male sterility
•     Paralysis
•     Death

Our attorneys work on a contingent fee basis, which means that you pay no fees unless there is a financial recovery for you.  There is no risk for you to join the lawsuit, have us investigate your case, and attempt to obtain a fair settlement for your injuries.

TRADEMARK NOTICE: Sprint Fidelis is a trademark of Medtronic Corporation.

The Carabin & Shaw Law Firm, its' lawyers and this website is in no way affiliated with Medtronic Corporation. The use of this mark is solely for informational and product identification purposes.

Other Medtronic recall information:

Three (3) different defibrillator malfunctions could occur as a result of the Medtronic Sprint Fidelis lead:

1. A massive electrical shock could be delivered to the heart, which could be lethal in some cases
2. The defibrillator could beep, alerting that there is a problem requiring immediate medical attention
3. The battery could deplete, causing the device to fail when it is needed to provide a life-saving shock

There is no consistently reliable test to predict whether the Medtronic lead will fracture in the future. However, despite the risk of malfunctions, experts are not recommending that the recalled Medtronic lead be surgically removed. Surgery to remove the wire or attepts to place a second lead in the chest carries a substantial risks, as it is a much more complex procedure than the initial insertion. The only recommendation that Medtronic has made to reduce the impact of their mistake, is that those who think they may have the Sprint Fidelis lead should contact their doctors who could reprogram the defibrillator to better monitor for lead problems. This should increase the likelihood that a fracture will be detected by the device before any harm is caused by an unnecessary shock.

This provides little reassurance to most individuals who have the defective Metronic lead placed in their chest. Even if a fracture is detected before the device malfunctions, they will still face the serious risks associated with implanting a second lead wire or replacing the current lead, which has an alarmingly high rate of complications. If you wish to speak to a lawyer on this matter call us toll free at 1-800-862-1260.